JP7650279B2 - トリスルフィド化合物 - Google Patents

トリスルフィド化合物 Download PDF

Info

Publication number
JP7650279B2
JP7650279B2 JP2022544576A JP2022544576A JP7650279B2 JP 7650279 B2 JP7650279 B2 JP 7650279B2 JP 2022544576 A JP2022544576 A JP 2022544576A JP 2022544576 A JP2022544576 A JP 2022544576A JP 7650279 B2 JP7650279 B2 JP 7650279B2
Authority
JP
Japan
Prior art keywords
pantethine
trisulfide
solution
equivalents
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022544576A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022045052A1 (cg-RX-API-DMAC7.html
Inventor
昌一郎 朝長
貴弘 磯部
悦男 大島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Pharma Chemical Co Ltd
Original Assignee
Kyowa Pharma Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Pharma Chemical Co Ltd filed Critical Kyowa Pharma Chemical Co Ltd
Publication of JPWO2022045052A1 publication Critical patent/JPWO2022045052A1/ja
Application granted granted Critical
Publication of JP7650279B2 publication Critical patent/JP7650279B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2022544576A 2020-08-27 2021-08-23 トリスルフィド化合物 Active JP7650279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020143639 2020-08-27
JP2020143639 2020-08-27
PCT/JP2021/030755 WO2022045052A1 (ja) 2020-08-27 2021-08-23 トリスルフィド化合物

Publications (2)

Publication Number Publication Date
JPWO2022045052A1 JPWO2022045052A1 (cg-RX-API-DMAC7.html) 2022-03-03
JP7650279B2 true JP7650279B2 (ja) 2025-03-24

Family

ID=80353266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544576A Active JP7650279B2 (ja) 2020-08-27 2021-08-23 トリスルフィド化合物

Country Status (7)

Country Link
US (1) US12534432B2 (cg-RX-API-DMAC7.html)
EP (1) EP4194437B1 (cg-RX-API-DMAC7.html)
JP (1) JP7650279B2 (cg-RX-API-DMAC7.html)
CN (1) CN115943140B (cg-RX-API-DMAC7.html)
ES (1) ES3054285T3 (cg-RX-API-DMAC7.html)
PL (1) PL4194437T3 (cg-RX-API-DMAC7.html)
WO (1) WO2022045052A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230009425A (ko) 2020-05-12 2023-01-17 더 제너럴 하스피탈 코포레이션 신경보호에서의 글루타티온 트리술피드 (gsssg)
CN117320709A (zh) 2021-07-08 2023-12-29 协和医药化工股份有限公司 帕金森病的预防或治疗药
US20260191823A1 (en) 2022-11-21 2026-07-09 Kyowa Hakko Bio Co., Ltd. Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent
WO2024143400A1 (ja) 2022-12-27 2024-07-04 協和ファーマケミカル株式会社 トリスルフィド化合物
WO2025070464A1 (ja) 2023-09-28 2025-04-03 協和ファーマケミカル株式会社 トリスルフィド化合物を含有する医薬組成物
WO2026058944A1 (ja) * 2024-09-13 2026-03-19 協和ファーマケミカル株式会社 非対称型のトリスルフィド化合物
WO2026127049A1 (ja) * 2024-12-11 2026-06-18 キリンホールディングス株式会社 老化細胞除去用組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000241A1 (en) 1994-06-27 1996-01-04 Pharmacia & Upjohn Ab Process for the preparation of peptide trisulfides
WO2020158894A1 (ja) 2019-01-30 2020-08-06 協和発酵バイオ株式会社 ポリスルフィド化合物を含有する組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (cg-RX-API-DMAC7.html) 1973-12-05 1978-02-01
JPS5819673B2 (ja) * 1976-08-26 1983-04-19 相互薬工業株式会社 パンテチンの製造方法
JP2928414B2 (ja) 1991-09-20 1999-08-03 ポーラ化成工業株式会社 皮膚外用剤
CN107652264A (zh) 2017-09-25 2018-02-02 苏州华诺医药有限公司 硫辛酸杂质a的制备方法
JP2022166333A (ja) * 2019-09-18 2022-11-02 国立大学法人 熊本大学 活性イオウ分子種生体内濃度上昇剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000241A1 (en) 1994-06-27 1996-01-04 Pharmacia & Upjohn Ab Process for the preparation of peptide trisulfides
WO2020158894A1 (ja) 2019-01-30 2020-08-06 協和発酵バイオ株式会社 ポリスルフィド化合物を含有する組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
第一部医薬品各条 は行，第十三改正日本薬局方解説書，第１版，株式会社廣川書店 廣川 節男，1996年，C-1986～C-1990

Also Published As

Publication number Publication date
ES3054285T3 (en) 2026-02-02
CN115943140A (zh) 2023-04-07
EP4194437A1 (en) 2023-06-14
EP4194437A4 (en) 2024-10-02
EP4194437B1 (en) 2025-11-12
EP4194437C0 (en) 2025-11-12
US20230357141A1 (en) 2023-11-09
JPWO2022045052A1 (cg-RX-API-DMAC7.html) 2022-03-03
US12534432B2 (en) 2026-01-27
CN115943140B (zh) 2024-10-01
PL4194437T3 (pl) 2026-02-02
WO2022045052A1 (ja) 2022-03-03

Similar Documents

Publication Publication Date Title
CN115943140B (zh) 三硫化物化合物
JP7684315B2 (ja) トリスルフィド化合物及びその包接体
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP7659282B2 (ja) トリスルフィド化合物を用いる、肝細胞増殖因子中のチロシン残基のニトロ化を防止する方法
CN106795175A (zh) 头孢菌素化合物的合成
AU2013269340A1 (en) Method of synthesising sulforaphane
US6160167A (en) Mercaptans and disulfides
EP4613739A1 (en) Trisulfide compound
MXPA06006709A (es) Proceso para sintetizar disulfuros.
WO2024143231A1 (ja) トリスルフィド化合物及びその包接体
US10414722B2 (en) Bioinspired catalysis using oligourea helical foldamers
EP0923932B1 (en) Composition containing antitumor agent
WO2026058944A1 (ja) 非対称型のトリスルフィド化合物
KR102207372B1 (ko) 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
JP2006520768A (ja) 金属イオンのキレート化剤として有用な窒素含有多環式誘導体およびそれらの用途
KR100469064B1 (ko) 2-메틸-4-이소티아졸린-3-온 염의 정제 방법
AU2005243793A1 (en) Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same
JPH07228528A (ja) 水溶性トラネキサム酸亜鉛化合物
US8975283B2 (en) Pharmacologically active compounds containing sulfur
KR100967444B1 (ko) Ｎ,ｎ'-디치환-3,3'-디티오프로피온아미드의 제조방법
FI76692C (fi) Foerfarande foer framstaellning av noskapinpreparat.
Griffin A molybdenum (V) model for nitrogenase enzyme.
EP0009996A1 (en) Preparation of vindesine monosulfate
CA2658076A1 (fr) Agents chelatants d'ions metalliques, leurs procedes de preparation et leurs applications
JP2008056622A (ja) セレノウレアおよび／またはチオウレアを含有することを特徴とする活性酸素消去物質とその利用法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250311

R150 Certificate of patent or registration of utility model

Ref document number: 7650279

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150